551 related articles for article (PubMed ID: 34712235)
1. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
Volpedo G; Pacheco-Fernandez T; Bhattacharya P; Oljuskin T; Dey R; Gannavaram S; Satoskar AR; Nakhasi HL
Front Immunol; 2021; 12():748325. PubMed ID: 34712235
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils and Visceral Leishmaniasis: Impact on innate immune response and cross-talks with macrophages and dendritic cells.
Kupani M; Pandey RK; Mehrotra S
J Cell Physiol; 2021 Apr; 236(4):2255-2267. PubMed ID: 33345353
[TBL] [Abstract][Full Text] [Related]
3. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
4. miR-21 Expression Determines the Early Vaccine Immunity Induced by
Gannavaram S; Bhattacharya P; Siddiqui A; Ismail N; Madhavan S; Nakhasi HL
Front Immunol; 2019; 10():2273. PubMed ID: 31608064
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis.
Pandey SC; Kumar A; Samant M
Parasite Immunol; 2020 Sep; 42(9):e12732. PubMed ID: 32418227
[TBL] [Abstract][Full Text] [Related]
7. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
8. Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated
Bhattacharya P; Dey R; Saxena A; Karmakar S; Ismail N; Gannavaram S; Dagur PK; Satoskar M; Satoskar S; De Paoli S; Takeda K; McCoy JP; Nakhasi HL
J Immunol; 2020 Dec; 205(12):3333-3347. PubMed ID: 33177159
[TBL] [Abstract][Full Text] [Related]
9. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
10. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
[TBL] [Abstract][Full Text] [Related]
11. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
[TBL] [Abstract][Full Text] [Related]
13. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
[TBL] [Abstract][Full Text] [Related]
15. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.
Selvapandiyan A; Dey R; Nylen S; Duncan R; Sacks D; Nakhasi HL
J Immunol; 2009 Aug; 183(3):1813-20. PubMed ID: 19592661
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell engineered cTXN as new vaccine prospect against L. donovani.
Suman SS; Kumar A; Singh AK; Amit A; Topno RK; Pandey K; Das VNR; Das P; Ali V; Bimal S
Cytokine; 2021 Sep; 145():155208. PubMed ID: 32736961
[TBL] [Abstract][Full Text] [Related]
17. Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis.
Karmakar S; Ismail N; Oliveira F; Oristian J; Zhang WW; Kaviraj S; Singh KP; Mondal A; Das S; Pandey K; Bhattacharya P; Volpedo G; Gannavaram S; Satoskar M; Satoskar S; Sastry RM; Oljuskin T; Sepahpour T; Meneses C; Hamano S; Das P; Matlashewski G; Singh S; Kamhawi S; Dey R; Valenzuela JG; Satoskar A; Nakhasi HL
Commun Biol; 2021 Jul; 4(1):929. PubMed ID: 34330999
[TBL] [Abstract][Full Text] [Related]
18. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
Manna PP; Hira SK; Basu A; Bandyopadhyay S
Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
[TBL] [Abstract][Full Text] [Related]
19. Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
Anand S; Madhubala R
Sci Rep; 2015 Jun; 5():10706. PubMed ID: 26035062
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.
Agallou M; Athanasiou E; Kammona O; Tastsoglou S; Hatzigeorgiou AG; Kiparissides C; Karagouni E
Front Immunol; 2019; 10():2749. PubMed ID: 31849951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
